Follow-up blood cultures in Staphylococcus aureus bacteremia: a probability-based optimization

Sam Van Goethem1, Hélène Boogaerts1, Matthias Cuykx1, Pol van den Bremen2, Kristien Wouters3, Herman Goossens1, Hilde Jansens1, Gerrit Luit ten Kate4
1Laboratory of Medical Microbiology, Antwerp University Hospital, Edegem, Belgium
2University of Antwerp, Edegem, Belgium
3Clinical Trial Center (CTC), CRC Antwerp, Antwerp University Hospital, University of Antwerp, Edegem, Belgium
4Department of General Internal Medicine, Infectious Diseases and Tropical Medicine, Antwerp University Hospital, Edegem, Belgium

Tóm tắt

Staphylococcus aureus bacteremia (SAB) is a relevant finding which prompts a thorough diagnostic work-up. Follow-up blood cultures (BC) are essential in this work-up. We investigate the probability of detecting an ongoing bacteremia after initiation of active therapy according to the number of BC taken at key time points. A retrospective analysis of all patients with SAB in a 6-year period was performed. Total number of BCs taken and the positivity was registered for each day after start of therapy. A positivity-rate was corrected using a logistic mixed effects model. Observed detection frequencies were applied to calculate detection probabilities using binomial distributions. Three hundred and seventeen cases were withheld for analysis. A BC bottle positivity rate of 66.7% was found 1 day after initiation of active therapy, which decreased to 48.5% on day 4. When using 1 set of FU-BC, 73.4% of persisting SABs are detected. To maintain a probability of detection of ≥ 90%, 2 BC sets should be taken on day 2 and day 4 after start of therapy. In 10 of 109 patients with positive FU-BC, skip phenomena were registered, with a significant higher proportion in patients with < 4 BC bottles taken (14%) than when ≥ 4 BC bottles were taken (4.1%). We recommend taking 2 BC sets on days 2 and 4 after start of therapy in order to detect ≥ 90% of persisting SABs, limiting skip phenomena and blood volume required. We strongly advice against taking a single BC set as follow-up for SAB.

Tài liệu tham khảo

Minejima E, Mai N, Bui N et al (2020) Defining the breakpoint duration of Staphylococcus aureus bacteremia predictive of poor outcomes. Clin Infect Dis 70:566–573 Ten Oever J, Jansen JL, Van Der Vaart TW, Schouten JA, Hulscher MEJL, Verbon A (2019) Development of quality indicators for the management of Staphylococcus aureus bacteraemia. J Antimicrob Chemother 74:3344–3351 Fowler VG, Olsen MK, Corey GR et al (2003) Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 163:2066 (Available at: http://archinte.jamanetwork.com/article.aspx?doi=10.1001/archinte.163.17.2066) Fowler VG, Justice A, Moore C et al (2005) Risk factors for hematogenous complications of intravascular catheter–associated Staphylococcus aureus bacteremia. Clin Infect Dis 40:695–703 (Available at: https://academic.oup.com/cid/article-abstract/40/5/695/364816) Rosa R, Wawrzyniak A, Sfeir M, Smith L, Abbo LM (2016) Performance of processes of care and outcomes in patients with Staphylococcus aureus bacteremia. J Hosp Med 11:27–32 Fowler VG Jr, Sanders LL, Sexton DJ, Kong L, Marr KA, Gopal AK, Gottlieb G, McClelland RS, Corey GR (1998) Outcome of Staphylococcus aureus bacteremia according to patients. Clin Infect Dis 27(3):478–486. https://doi.org/10.1086/514686 Borde JP, Batin N, Rieg S et al (2014) Adherence to an antibiotic stewardship bundle targeting Staphylococcus aureus blood stream infections at a 200-bed community hospital. Infection 42:713–719 López-Cortés LE, Del Toro MD, Gálvez-Acebal J et al (2013) Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of staphylococcus aureus bacteremia. Clin Infect Dis 57:1225–1233 Nagao M, Yamamoto M, Matsumura Y et al (2017) Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis. Infection 45:83–91 Cockerill FR, Wilson JW, Vetter EA et al (2004) Optimal testing parameters for blood cultures. Clin Infect Dis 38:1724–1730 Lee A, Mirrett S, Reller LB, Weinstein MP (2007) Detection of bloodstream infections in adults: How many blood cultures are needed? J Clin Microbiol 45:3546–3548 Fiala J, Palraj BR, Sohail MR, Lahr B, Baddour LM (2019) Is a single set of negative blood cultures sufficient to ensure clearance of bloodstream infection in patients with Staphylococcus aureus bacteremia? The skip phenomenon. Infection 47:1047–1053 Liu C, Bayer A, Cosgrove SE, et al (2011) Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52 Kim T, Lee SC, Kim MJ et al (2020) Clinical significance of follow-up blood culture in patients with a single Staphylococcus aureus-positive blood culture. Infect Dis (Auckl) 52:207–212 Khatib R, Schaffer C, Johnson LB (2002) Staphylococcus aureus in a single positive blood culture: causes and outcome. Scand J Infect Dis 34:645–647 (Available at: http://www.tandfonline.com/doi/full/10.1080/00365540210147994) Heo M, Leon AC (2005) Performance of a mixed effects logistic regression model for binary outcomes with unequal cluster size. J Biopharm Stat 15:513–526 Go JRU, Baddour LM, Lahr B, Sohail MR, Palraj R (2021) 9. The skip phenomenon in Staphylococcus aureus bacteremia: clinical associations. Open Forum Infect Dis 8:S7–S8 (Available at: https://academic.oup.com/ofid/article/8/Supplement_1/S7/6449584)